HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M J Moore Selected Research

Prostatic Neoplasms (Prostate Cancer)

1/2005Randomized phase II study of two doses of gefitinib in hormone-refractory prostate cancer: a trial of the National Cancer Institute of Canada-Clinical Trials Group.
9/2003Randomized, double-blind, controlled trial of mitoxantrone/prednisone and clodronate versus mitoxantrone/prednisone and placebo in patients with hormone-refractory prostate cancer and pain.
8/2001Treatment of hormone refractory prostate cancer.
6/2001A retrospective analysis of the relationship between changes in serum PSA, palliative response and survival following systemic treatment in a Canadian randomized trial for symptomatic hormone-refractory prostate cancer.
5/2000Prostate specific antigen response to mitoxantrone and prednisone in patients with refractory prostate cancer: prognostic factors and generalizability of a multicenter trial to clinical practice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M J Moore Research Topics

Disease

11Pancreatic Neoplasms (Pancreatic Cancer)
12/2023 - 11/2000
10Neoplasms (Cancer)
01/2017 - 08/2000
6Pain (Aches)
12/2023 - 08/2001
6Colorectal Neoplasms (Colorectal Cancer)
02/2014 - 09/2000
5Adenocarcinoma
09/2016 - 09/2003
5Prostatic Neoplasms (Prostate Cancer)
01/2005 - 05/2000
4Urinary Bladder Neoplasms (Bladder Cancer)
08/2023 - 09/2000
4Transitional Cell Carcinoma
08/2023 - 09/2000
4Exanthema (Rash)
07/2014 - 04/2003
2Hemorrhage
08/2023 - 09/2000
2Hematuria
08/2023 - 09/2000
2Neoplasm Metastasis (Metastasis)
05/2006 - 09/2003
2Breast Neoplasms (Breast Cancer)
02/2001 - 08/2000
2Neutropenia
11/2000 - 09/2000
1Colonic Neoplasms (Colon Cancer)
07/2015
1Disease Progression
04/2013
1Blister (Bulla)
08/2012
1Infections
07/2012
1Inflammation (Inflammations)
05/2009
1Acute Coronary Syndrome
05/2009
1Vascular System Injuries
05/2009
1Out-of-Hospital Cardiac Arrest
12/2008
1Atrial Fibrillation
07/2008
1Biliary Tract Neoplasms (Biliary Tract Cancer)
05/2004
1Carcinoma (Carcinomatosis)
09/2003
1Agranulocytosis (Granulocytopenia)
04/2003
1Renal Cell Carcinoma (Grawitz Tumor)
04/2003
1Dementia (Dementias)
07/2001
1Hypoxia (Hypoxemia)
05/2001

Drug/Important Bio-Agent (IBA)

14GemcitabineFDA Link
12/2023 - 09/2000
5Fluorouracil (Carac)FDA LinkGeneric
12/2023 - 09/2000
5Doxorubicin (Adriamycin)FDA LinkGeneric
08/2023 - 08/2000
5Hormones (Hormone)IBA
01/2005 - 05/2000
3Analgesics (Analgesic Drugs)IBA
12/2023 - 08/2002
3Cisplatin (Platino)FDA LinkGeneric
08/2023 - 09/2000
3Methotrexate (Mexate)FDA LinkGeneric
08/2023 - 09/2000
3Vinblastine (Vinblastine Sulfate)FDA Link
08/2023 - 09/2000
3Cetuximab (Erbitux)FDA Link
07/2015 - 04/2013
3Erlotinib Hydrochloride (CP 358,774)FDA Link
07/2014 - 04/2006
3Irinotecan (Camptosar)FDA LinkGeneric
02/2014 - 09/2000
3NucleosidesIBA
09/2003 - 11/2000
3Prednisone (Sone)FDA LinkGeneric
09/2003 - 05/2000
3Mitoxantrone (Novantrone)FDA LinkGeneric
09/2003 - 05/2000
2Leucovorin (Folinic Acid)FDA Link
02/2014 - 09/2000
2DNA (Deoxyribonucleic Acid)IBA
08/2012 - 05/2001
2ErbB Receptors (EGF Receptor)IBA
04/2006 - 01/2005
1Dasatinib (BMS 354825)FDA Link
01/2017
1src-Family KinasesIBA
01/2017
15- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA
09/2016
1Heat-Shock Proteins (Heat-Shock Protein)IBA
09/2016
1ganitumabIBA
05/2015
1tremelimumabIBA
09/2014
1EpiregulinIBA
02/2014
1Biomarkers (Surrogate Marker)IBA
02/2014
1folfirinoxIBA
02/2014
1Oxaliplatin (Eloxatin)FDA LinkGeneric
02/2014
1Cyclophosphamide (Cytoxan)FDA LinkGeneric
04/2013
1Sorafenib (BAY 43-9006)FDA Link
04/2013
1Troponin T (Troponin T1)IBA
05/2009
1Fatty Acid Binding Protein 3IBA
05/2009
1Hemostatics (Antihemorrhagics)IBA
05/2009
13-aminopyridine-2-carboxaldehyde thiosemicarbazone (triapine)IBA
12/2007
1Alkaline PhosphataseIBA
05/2006
1Tyrosine Kinase InhibitorsIBA
04/2006
1Gefitinib (Iressa)FDA Link
01/2005
1liposomal doxorubicin (Doxil)FDA Link
09/2003
1Bay 12-9566IBA
09/2003
1Clodronic Acid (Clodronate)IBA
09/2003
11-dodecylpyridoxal (PLD)IBA
09/2003
1Matrix Metalloproteinase InhibitorsIBA
09/2003
1SteroidsIBA
04/2003
1troxacitabineIBA
04/2003
1Morphine (MS Contin)FDA LinkGeneric
08/2002
1lipid-associated sialic acid (LASA)IBA
08/2002
1Cytotoxins (Cytolysins)IBA
08/2001
1Mitogen-Activated Protein KinasesIBA
05/2001
1Phosphotransferases (Kinase)IBA
05/2001
1p38 Mitogen-Activated Protein KinasesIBA
05/2001
1Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA
05/2001
1MitogensIBA
05/2001
1Pertussis ToxinIBA
05/2001
1Proteins (Proteins, Gene)FDA Link
05/2001
14- (4- fluorophenyl)- 2- (4- hydroxyphenyl)- 5- (4- pyridyl)imidazoleIBA
05/2001
1Antisense OligonucleotidesIBA
05/2001
12- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA
05/2001
1JNK Mitogen-Activated Protein KinasesIBA
05/2001
1GTP-Binding Proteins (G-Protein)IBA
05/2001
1Radioisotopes (Radionuclides)IBA
02/2001
1SuspensionsIBA
02/2001
1Tretinoin (Retinoic Acid)FDA LinkGeneric
01/2001

Therapy/Procedure

9Therapeutics
12/2023 - 09/2000
9Drug Therapy (Chemotherapy)
09/2016 - 08/2002
2Platelet Transfusion (Blood Platelet Transfusions)
08/2023 - 09/2000
2Defibrillators (Defibrillator)
12/2008 - 07/2008
1Electric Countershock (Cardioversion)
07/2008
1Withholding Treatment
11/2005
1Intravenous Infusions
09/2003
1Premedication
04/2003
1Palliative Care (Palliative Therapy)
08/2001
1Patient Care
07/2001